For over 160 years, we’ve been innovating to make the world a healthier place. Visit https://t.co/YjZgM1r3ic to learn more. https://t.co/K5kUC0xMQ2
UPDATE: The @MHRAgovuk issued a temporary authorization for emergency use of our #COVID19 vaccine with @BioNTech_Group in the United Kingdom. This marks the first authorization of a vaccine to help fight the pandemic following a worldwide trial.
NEWS: @NEJM published safety and final efficacy results from the Phase 3 trial of our #COVID19 vaccine, developed w/ @BioNTech_Group , confirming the candidate was well tolerated & demonstrated a 95% efficacy in those who participated in the trial.
NEWS: The @biontech_group '>Pfizer @BioNTech_Group #COVID19 vaccine has not been approved or licensed by the @US_FDA but has been authorized for emergency use to prevent COVID-19 in individuals 16 & older. See conditions of use:
The Pfizer-BioNTech COVID-19 vaccine has not been approved or licensed by the U.S. FDA but has been authorized for emergency use to prevent COVID-19 in individuals 16+. See conditions of use:
📸: The first shipment from our Kalamazoo plant. @UPS @FedEx . . The Pfizer-BioNTech #COVID19 vaccine has not been approved or licensed by the @US_FDA but has been authorized for emergency use to prevent COVID-19 in individuals 16+. See conditions of use:
James knows what it takes to get our medicines and #vaccines transported safely to patients around the globe. Nickname: “The Ice Man” 🧊 Job: Temperature Control Logistics 📦 #RealPeopleRealVoices
NEWS: Today we announced a second agreement with the U.S. government to supply our #COVID19 vaccine, developed with @BioNTech_Group , to Operation Warp Speed. Read about the agreement here:
In additional to a #vaccine , antivirals can play an important role in fighting viruses. Our investigational #antiviral for #COVID19 is currently in clinical trials and we are hopeful for its success.
Loading
UPDATE: We are proud to announce, along with @BioNTech_Group , that our mRNA-based #vaccine candidate has, at an interim analysis, demonstrated initial evidence of efficacy against #COVID19 in participants without prior evidence of SARS-CoV-2 infection.
BREAKING: We are proud to announce, along with @BioNTech_Group , that the Phase 3 study of our #COVID19 vaccine candidate has met all primary efficacy endpoints.
An update from @AlbertBourla on our investigational #COVID19 vaccine program with @BioNTech_Group .
#COVID19 UPDATE: We will submit a request today to the @US_FDA for Emergency Use Authorization (EUA) of our mRNA vaccine candidate with @BioNTech_Group .
It has before. It will again. Why we believe, that SCIENCE will win. RT if you agree. #ScienceWillWin #InItTogether
Imagine a world without #science . This #EarthDay , we're proud to stand behind our scientists & the #ScienceMarch . ????????
Loading